Focusing on advanced stages of CKD (stages 3–5, n = 130) did not change the associations of GFR, EPO and ferritin with hepcidin levels, whereas hypertension and dyslipidemia lost significance (detailed data not shown). This evidence concerns the gene EPO and Hypertension.